Ahmet Karaburun

Dr. Ahmet Karaburun


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AKAhmet Karaburun
Ahmet Karaburun
BÇBetül Kaya Çavuşoğlu
Betül Kaya Çavuşoğlu
UÇUlviye ACAR ÇEVİK
Ulviye ACAR ÇEVİK
DODerya Osmaniye
Derya Osmaniye
Begüm Nurpelin Sağlık ÖzkanBegüm Nurpelin Sağlık Özkan
Begüm Nurpelin Sağlık Özkan
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
Discovery of novel anticandidal agents with clarified mechanisms of action, could be a rationalist approach against diverse pathogenic fungal strains due to the rise of resistance to existing drugs. In support to this hypothesis, in this paper, a series of benzimidazole-oxadiazole compounds were synthesized and subjected to antifungal activity evaluation. In vitro activity assays indicated that some of the compounds exhibited moderate to potent antifungal activities against tested Candida species when compared positive control amphotericin B and ketoconazole. The most active compounds 4h and 4p were evaluated in terms of inhibitory activity upon ergosterol biosynthesis by an LC-MS-MS method and it was determined that they inhibited ergosterol synthesis concentration dependently. Docking studies examining interactions between most active compounds and lanosterol 14-α-demethylase also supported the in vitro results.

29 November 2018 in Molecules
Verified
Journal Article
Open access
PDF file
AKAhmet Karaburun
Ahmet Karaburun
UÇUlviye ACAR ÇEVİK
Ulviye ACAR ÇEVİK
DODerya Osmaniye
Derya Osmaniye
Begüm Nurpelin Sağlık ÖzkanBegüm Nurpelin Sağlık Özkan
Begüm Nurpelin Sağlık Özkan
BÇBetül Kaya Çavuşoğlu
Betül Kaya Çavuşoğlu
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
With the goal of obtaining a novel bioactive compound with significant antifungal activity, a series of 1,3,4-thiadiazole derivatives (3a–3l) were synthesized and characterized. Due to thione-thiol tautomerism in the intermediate compound 2, type of substitution reaction in the final step was determined by two-dimensional (2D) NMR. In vitro antifungal activity of the synthesized compounds was evaluated against eight Candida species. The active compounds 3k and 3l displayed very notable antifungal effects. The probable mechanisms of action of active compounds were investigated using an ergosterol quantification assay. Docking studies on 14-α-sterol demethylase enzyme were also performed to investigate the inhibition potency of compounds on ergosterol biosynthesis. Theoretical absorption, distribution, metabolism, and excretion (ADME) predictions were calculated to seek their drug likeness of final compounds. The results of the antifungal activity test, ergosterol biosynthesis assay, docking study, and ADME predictions indicated that the synthesized compounds are potential antifungal agents, which inhibit ergosterol biosynthesis probably interacting with the fungal 14-α-sterol demethylase.